Evidence map›Paper›PMID 33392667›Full record

ArticleEuropean journal of clinical pharmacology2021

ACE inhibitor-related angioedema in a COVID-19 patient-a plausible contribution of the viral infection?

Michał Kuzemczak, Charalampos Kavvouras, Mohammad Alkhalil, Mark Osten

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michał KuzemczakPeter Munk Cardiac Centre, Division of Cardiology, Toronto General Hospital, University Health Network, 585 University Avenue, Toronto, Ontario, M5G 2C4, Canada. michal.kuzemczak@gmail.com.ORCID http://orcid.org/0000-0003-0453-642X
Charalampos KavvourasPeter Munk Cardiac Centre, Division of Cardiology, Toronto General Hospital, University Health Network, 585 University Avenue, Toronto, Ontario, M5G 2C4, Canada.
Mohammad AlkhalilPeter Munk Cardiac Centre, Division of Cardiology, Toronto General Hospital, University Health Network, 585 University Avenue, Toronto, Ontario, M5G 2C4, Canada.
Mark OstenPeter Munk Cardiac Centre, Division of Cardiology, Toronto General Hospital, University Health Network, 585 University Avenue, Toronto, Ontario, M5G 2C4, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AngioedemaAngiotensin-Converting Enzyme InhibitorsCOVID-19Myocardial InfarctionRamiprilCardiovascular AgentsCoronary AngiographyCOVID-19 Nucleic Acid TestingDrug SubstitutionHumansMaleMiddle AgedPatient Care ManagementPlatelet Aggregation InhibitorsSARS-CoV-2Treatment OutcomeAngiotensin-Converting Enzyme InhibitorsCardiovascular AgentsPlatelet Aggregation InhibitorsRamipril

Identifiers

PMID33392667
PMCPMC7779079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.